Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...

Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

COLCHICINE has been shown to inhibit deoxyribonuclease and de-phosphorylation and de-amination of deoxyribonucleotides 1. The beneficial effect of colchicine in gout is possibly due to the effect ...

Researchers from Qingdao University described the discovery and preclinical characterization of a novel series of tubulin polymerization inhibitors that led to the identification of [I] as the most ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

WASHINGTON, DC—The short-term use of colchicine at the time of TAVI for severe aortic stenosis may curb the risk of new-onset atrial fibrillation (AF) and the need for a new permanent pacemaker, the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

WASHINGTON, DC – OCTOBER 29, 2024 – The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce ...

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce ...